The French gene therapy company established its U.S. headquarters in Philadelphia earlier this year.
Read the full article at: www.bizjournals.com
Read the press release at: https://sparingvision.com/sparingvision-raises-e75-million-series-b-to-continue-building-world-leading-portfolio-of-genomic-medicines-for-ocular-diseases-2/
